section name header

Pronunciation

be-KAP-lerm-in

Classifications

Therapeutic Classification: wound/ulcer/decubiti healing agent

Pharmacologic Classification: platelet derived growth factors

Indications

REMS


Action

  • Promotes chemotaxis of cells involved in wound repair and enhances formation of granulation tissue.
Therapeutic effects:
  • Improved healing.

Pharmacokinetics

Absorption: Minimal absorption (<3%).

Distribution: Action is primarily local.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

(improvement in ulcer healing)

ROUTEONSETPEAKDURATION
Topicalwithin 10 wkunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: erythematous rash at application site

Misc: MALIGNANCY

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Regranex